<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">Iron overload</z:e> sometimes complicates the clinical course of bone marrow transplantation and can cause damage to liver and heart function </plain></SENT>
<SENT sid="1" pm="."><plain>A patient with post-transplantation secondary <z:mp ids='MP_0005638'>hemochromatosis</z:mp> was treated with <z:chebi fb="0" ids="49005">deferasirox</z:chebi>, which not only normalized ferritin levels, but also reduced hepatic iron to <z:mpath ids='MPATH_458'>normal</z:mpath> values as measured by biosusceptometry with a superconducting quantum interference device </plain></SENT>
<SENT sid="2" pm="."><plain>Side effects were minimal </plain></SENT>
<SENT sid="3" pm="."><plain>The use of <z:chebi fb="0" ids="49005">deferasirox</z:chebi> to reduce post-transplant iron burden merits evaluation in a larger patient population </plain></SENT>
</text></document>